Advertisement

Topics

Manufacturing issues threaten delay for Aerie eye drug

08:10 EDT 10 Aug 2017 | BioPharmaDive

But Aerie believes the issues at its third party manufacturer's facility will be resolved before the expected decision date for its glaucoma med Rhopressa. 

Original Article: Manufacturing issues threaten delay for Aerie eye drug

NEXT ARTICLE

More From BioPortfolio on "Manufacturing issues threaten delay for Aerie eye drug"

Quick Search
Advertisement
 

Relevant Topic

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...